BIOMAT Database Logo BIOMAT Database Logo

Synergistic combinations of antimicrobial agents against anaerobic bacteria. 1987

I Brook

Studies evaluating the in vitro and in vivo synergistic potential of combined antimicrobial agents against anaerobic bacteria are reviewed. Most studies evaluated therapy against Bacteroides sp. (mostly Bacteroides fragilis group). The combinations found to be most effective against B. fragilis were between metronidazole and clindamycin, spiramycin or gentamicin and between clindamycin and aminoglycosides. Against Bacteroides melaninogenicus the effective combinations were penicillin or clindamycin plus gentamicin and metronidazole and spiramycin or gentamicin. Occasional synergy was observed against Clostridium sp. and anaerobic cocci with clindamycin and gentamicin. Synergistic combinations have the potential of clinical use in serious anaerobic infections.

UI MeSH Term Description Entries
D003013 Clostridium A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria
D001439 Bacteroides A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.

Related Publications

I Brook
Antimicrobial activity of antituberculosis agents against anaerobic bacteria.
May 1979, Chest,
I Brook
Activity of ten antimicrobial agents against anaerobic bacteria.
July 1978, The Journal of antimicrobial chemotherapy,
I Brook
In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria.
November 2000, International journal of antimicrobial agents,
I Brook
Susceptibility of anaerobic bacteria to antimicrobial agents.
January 1988, Pathology,
I Brook
Resistance of anaerobic bacteria to antimicrobial agents.
January 1991, Reviews of infectious diseases,
I Brook
In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
December 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
I Brook
In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria.
February 2022, Antibiotics (Basel, Switzerland),
I Brook
Anaerobic bacteria. Pathogenicity and relevant antimicrobial agents.
January 1984, Scandinavian journal of gastroenterology. Supplement,
I Brook
Synergistic antimicrobial activity of combinations of sanguinarine and EDTA with vancomycin against multidrug resistant bacteria.
January 2014, Drug metabolism letters,
I Brook
Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa.
January 1999, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!